Skip to main content
SpringerLink
Log in

Symptomatic and Supportive Care

  • Chapter
Bone Metastases

  • 81 Accesses

Abstract

Some symptoms, such as general weakness, poor appetite and weight loss, that patients experience when they have widespread cancer with soft tissue spread will also be present in patients who have bone metastases. In this chapter, however, the main focus will be on those symptoms more particularly caused by the bone involvement itself such as bone pain, poor mobility or anaemia, and the psychological support needed by such patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams F, Cruz L, Deachman MJ, Zamora E (1989) Focal subdermal toxicity with subcutaneous opioid infusion in patients with cancer pain. J Pain Symptom Management 4:31–33

    Article  CAS  Google Scholar 

  • Baines M (1989) Pain relief in active patients with cancer: analgesic drugs are the foundation of management. Br Med J 298:36–38

    Article  CAS  Google Scholar 

  • Barkas G, Duafala ME (1988) Advances in cancer pain management: a review of patient-controlled analgesia. J Pain Symptom Management 3:150–160

    Article  CAS  Google Scholar 

  • Bennett A, Melhuish PB, Patel S, Randies H, Stamford IF (1987) Cancer in mice; effects of prednisolone on mepacrine alone and with cytotoxic drugs. Br J Cancer 55:385–388

    Article  PubMed  CAS  Google Scholar 

  • Blanchard J, Menk E, Ramamurthy S, Hoffman J (1990) Subarachnoid and epidural calcitonin in patients with pain due to metastatic cancer. J Pain Symptom Management 5:42–45

    Article  CAS  Google Scholar 

  • Braga P, Ferri S, Santagostino A et al. (1978) Lack of opiate receptor involvement in centrally induced calcitonin analgesia. Life Sci 22:971–978

    Article  PubMed  CAS  Google Scholar 

  • Brescia FJ Sr, Walsh M, Savarese JJ, Kaiko RF (1987) A study of controlled-release oral morphine (MS Cortin) in an advanced cancer hospital. J Pain Symptom Management 2:193–198

    Article  CAS  Google Scholar 

  • Bruera E, Brenneis C, Paterson AH (1989) Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symtom Management 4:3–6

    Article  CAS  Google Scholar 

  • Budd K (1983) Buprenorphine. Clin Anaesthesiol 1:147–152

    CAS  Google Scholar 

  • Candeletti S, Ferri S (1990) Calcitonin-related peptides in the modulation of nociceptive stimuli. In: Lipton S, Tunks E, Zoppi M (eds) Advances in pain research and therapy, vol 13. Raven Press, New York, pp 45–53

    Google Scholar 

  • Chabal C, Buckley P, Jacobsen L, Butler S, Murphy T (1989) Long-term epidural morphine in the treatment of cancer pain. Pain Clinic 3:1–23

    Article  Google Scholar 

  • Closs S, Bates T (1987) The management of malignant spinal cord compression. In: Bates T (ed) Contemporary palliation of difficult symptoms. Baillière’s clinical oncology, vol 1, no. 4, pp 431–441

    Google Scholar 

  • Couch JR, Ziegler DK, Hassanein R (1976) Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of anti-migraine and anti-depressant drugs. Neurology 26: 121–127

    CAS  Google Scholar 

  • Derogatis LR, Morrow GR, Fetting J et al. (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757

    Article  PubMed  CAS  Google Scholar 

  • Dickey RP, Minton JP (1972) Levodopa relief of bone pain from breast cancer. New Engl J Med 286:843

    PubMed  CAS  Google Scholar 

  • Doyle D (1987) Symptom control in domiciliary terminal care. Churchill Livingstone, Edinburgh, London, Melbourne, New York, pp 22–51

    Google Scholar 

  • Driessen JJ, de Molder PHM, Claessen JJL, van Diejen D, Wobbes TL (1989) Epidural administration of morphine for control of cancer pain. Long-term efficacy and complications. Clin J Pain 5:217–222

    Article  PubMed  CAS  Google Scholar 

  • Drug and Therapeutics Bulletin (1987) Which NSAID? (19 Oct, p 81). A Postcript and a correction; 25:103

    Google Scholar 

  • Duthie AM (1983) Pituitary cryoablation. Anaesthesia 38:495–497

    PubMed  CAS  Google Scholar 

  • Engelsman E, Heuson JC, Blonk-Van Der Wijst J et al. (1975) Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an EORTC study. Br Med J 2:714–715

    Article  PubMed  CAS  Google Scholar 

  • Filshie J (1988) The non-drug treatment of neuralgic and neuropathic pain of malignancy. Cancer Surv 7:161–193

    PubMed  CAS  Google Scholar 

  • Gennari C (1983) Clinical aspects of calcitonin in pain. Triangle 22:157–163

    Google Scholar 

  • Gennari C, Chierichetti SM, Piolini M et al. (1985a) Analgesic activity of salmon and human calcitonin against cancer pain: A double-blind, placebo-controlled clinical study. Curr Ther Res 38:298–308

    Google Scholar 

  • Gennari C, Francini G, Gommelli B, Bigazzi S (1985b) Treatment of bone metastasis with antiresorption drugs. In Garrattini S (ed). Bone resorption, metastasis and diphosphonates. Raven Press, New York, pp 127–136

    Google Scholar 

  • Hanks GW (1984) Psychotrophic drugs. Clin Oncol 3:135–151

    Google Scholar 

  • Hanks GW (1988) The pharmacological treatment of bone pain. Cancer Surv 7:87–101

    PubMed  CAS  Google Scholar 

  • Hanks GW, Hoskin PJ (1987) Opioid analgesics in the management of patients with cancer: a review. Pall Med 1:1–25

    Article  Google Scholar 

  • Hanks GW, Trueman T, Twycross RG (1983) Corticosteroids in terminal cancer -a prospective analysis of current practice. Postgrad Med J 59:702–706

    Article  PubMed  CAS  Google Scholar 

  • Hardy PAJ, Wells JCD (1990) Patient controlled intrathecal morphine for cancer pain: a method used to assess morphine requirements and bolus doses. Clin J Pain 6:57–59

    Article  PubMed  CAS  Google Scholar 

  • Heyse-Moore L, Johnson-Bell VG (1987) Can doctors accurately predict the expectancy of patients with terminal cancer? Pall Med 1:165–166

    Article  Google Scholar 

  • Hinton J (1972) Dying. Penguin Books, Harmondsworth, Middx, pp 79–93

    Google Scholar 

  • Hunton J (1989) Metastatic bone pain. Mediq Ltd, London Inturrisi CE, Umans JG (1983) Pethidine and its active metabolite, norpethidine. Clin Anaesthesiol 1:123–138

    Google Scholar 

  • Kanner RM, Portenoy RK (1986) Unavailability of narcotic analgesics for ambulatory cancer patients in New York City. J Pain Symptom Management 1:87–89

    Article  CAS  Google Scholar 

  • Kessel S, Wörz R (1987) Immediate response of phantom limb pain to calcitonin. Pain 30:79–87

    Article  PubMed  CAS  Google Scholar 

  • Lamerton R (1980) Care of the dying. Penguin Books, Harmondsworth, Middx, pp 63–92

    Google Scholar 

  • Lipton S (1989) Pain relief in active patients with cancer: the early use of nerve blocks improves the quality of life. Br Med J 298:37–38

    Article  CAS  Google Scholar 

  • Madrid Jose L, Fatela LV, Alcorta J, Guillen F, Lobato RD (1988) Intermittent intrathecal morphine by means of an implantable reservoir: a survey of 100 cases. J Pain Symptom Management 3:67–71

    Article  CAS  Google Scholar 

  • Maher R, Mehta M (1977) Spinal (intrathecal) and extradural analgesia. In: Lipton S (ed) Persistent pain: modern methods of treatment, vol 1. Academic Press, London, pp 61-–99

    Google Scholar 

  • Masters NJ, Bennett MRD, Wedley JR (1985) Nebulised morphine: a new delivery method for pain relief. Practitioner 229:649–653

    PubMed  CAS  Google Scholar 

  • Max MB, Culnane M, Schafer SC et al. (1987) Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589–596

    PubMed  CAS  Google Scholar 

  • McGuire DB, Barbour L, Boxler J et al. (1987) Fixed-interval v as-needed analgesics in cancer outpatients. J Pain Symptom Management 2:199–205

    Article  CAS  Google Scholar 

  • Melzack R, Wall PD (1965) Pain mechanisms: a new theory. Science 150:971–979

    Article  PubMed  CAS  Google Scholar 

  • Miles J (1984) Pituitary destruction. In: Wall PD, Melzack R (eds) Textbook of pain. Churchill Livingstone, London, pp 656–665

    Google Scholar 

  • Minton JP, Bronn DG, Kibbey WE (1976) L-dopa effect in painful bony metastases. N Engl J Med 294:340

    PubMed  CAS  Google Scholar 

  • Miser AW, Moore L, Greene R, Gracely RH, Miser JS (1986) Prospective study of continuous intravenous and subcutaneous morphine infusions for therapy-related or cancer-related pain in children and young adults with cancer. Clin J Pain 2:101–106

    Article  Google Scholar 

  • Morrica G (1977) Pituitary adenolysis in the treatment of intractable pain from cancer. In: Lipton S (ed). Persistent pain: modern methods of treatment, vol 1. Academic Press, London, pp 149–174

    Google Scholar 

  • Nitescu P, Moulin DE, Coyle N (1986) Spinal opioid analgesics and local anaesthetics in the management of chronic cancer pain. J Pain Symptom Management 1:79–86

    Article  Google Scholar 

  • Nitescu P, Appelgren L, Linder LE, Sjöberg M, Hultman E, Curelaru I (1990) Epidural versus intrathecal morphine-bupivacaine; assessment of consecutive treatment in advanced cancer pain. J Pain Symptom Management 5:18–26

    Article  CAS  Google Scholar 

  • Noda J, Umeda S, Arai T, Harima A, Mori K (1989) Continuous subcutaneous infusion of buprenorphine for cancer pain control. Clin J Pain 5:147–152

    Article  PubMed  CAS  Google Scholar 

  • Panerai AE, Sacerdote P, Bianchi M et al. (1990) Neuropharmacological approach to nociception. In: Lipton S, Janks E, Zoppi M (eds) Advances in pain research and therapy, vol 13. Raven Press, New York, pp 41–44

    Google Scholar 

  • Parkes CM (1972) Accuracy in predictions of survival in later stages of cancer. Br Med J ii:29–31

    Google Scholar 

  • Pecile A, Ferri S, Braga PC et al. (1975) Effects of intracerebroventricular calcitonin in the conscious rabbit. Experientia 31:322–333

    Article  Google Scholar 

  • Plumb M, Holland J (1977) Comparative studies of psychological function in patients with advanced cancer. I. Self reported depressive symptoms. Psychosom Med 39:264–276

    PubMed  CAS  Google Scholar 

  • Ramirez A (1989) Liaison psychiatry in a breast cancer unit. J R Soci Med 82:15–17

    CAS  Google Scholar 

  • Regnard C (1985) A guide to symptom relief in advanced cancer. Haigh and Hochland, Manchester, pp 19–40

    Google Scholar 

  • Richlin DM, Jamron LM, Novick NL (1987) Cancer pain control with a combination of methadone, amitriptyline, and non-narcotic analgesic therapy: a case series analysis. J Pain Symptom Management 2:89–94

    Article  CAS  Google Scholar 

  • Rogers AG (1986) The use and availability of rectal narcotics. J Pain Symptom Management 1:229–230

    Article  CAS  Google Scholar 

  • Rogers AG (1987) The use of continuous subcutaneous infusion of narcotics in chronic cancer pain. J Pain Symptom Management 2:167–168

    Article  CAS  Google Scholar 

  • Rogers AG (1988) When all oral opioids cause nausea and vomiting. J Pain Symptom Management 3:114

    Article  CAS  Google Scholar 

  • Satoh M, Amano H, Takahiro N et al. (1979) Inhibition by calcium of analgesia induced by intracisternal injection of porcine calcitonin in mice. Res Commun Chem Pathol Pharmacol 26:213–216

    PubMed  CAS  Google Scholar 

  • Savarese JJ, Shepherd L, Krant MJ (1987) Long acting morphine in cancer pain analgesia. Clin J pain 3:177–181

    Article  Google Scholar 

  • Schiraldi GF, Scoccia S, Soresi E (1985) Analgesic activity of high doses of salmon calcitonin in lung cancer. Curr Ther Res 38:592

    Google Scholar 

  • Schug SA, Zech D, Dörr U (1990) Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Management 5:27–32

    Article  CAS  Google Scholar 

  • Sjolin SU, Trykker H (1985) Unsuccessful treatment of severe pain from bone metastases with sinemet, 25/100. N Engl J Med 312:650–651

    PubMed  CAS  Google Scholar 

  • Stein C, Brechner T (1987) Epidural morphine tolerance: use of norepinephrine. Clin J Pain 2:267–269

    Article  Google Scholar 

  • Stjernswärd J (1985) Cancer pain relief: an important global public health issue. Clin J Pain 1:95–97

    Article  Google Scholar 

  • Storey P, Hill HH Jr, St Louis RH, Tarver EE (1990) Subcutaneous infusion for control of cancer symptoms. J Pain Symptom Management 5:33–41

    Article  CAS  Google Scholar 

  • Swerdlow M (1986) Anticonvulsants in the therapy of neuralgic pain. Pain Clin 1:9–19

    Google Scholar 

  • Swerdlow M (1990) The role of chemical neurolysis. In: Lipton S, Tunks E, Zoppi M (eds) Advances in pain research and therapy, vol 13. Raven Press, New York, pp 315–317

    Google Scholar 

  • Thompson JW (1988) Pharmacology of transcutaneous electrical nerve stimulation (TENS). J Intract Pain Soc 7:33–40

    Google Scholar 

  • Toscani F, Carini M (1989) The implementation of WHO guidelines for the treatment of advanced cancer pain at a district general hospital in Italy. Pain Clin 3:37–48

    Google Scholar 

  • Twycross RG (1988) Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv 7:29–53

    PubMed  CAS  Google Scholar 

  • Twycross RG, Lack SA (1983) Symptom control in far-advanced cancer: pain relief. Pitman, London

    Google Scholar 

  • Ullman DA, Quarmby R (1989) Epidural administration of bupivacaine and morphine in chronic cancer pain. Pain Clin 3:25–29

    Google Scholar 

  • Ventafridda V, Ripamonti C, Bianchi M, Sbanotto A, Deconno F (1986a) A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Management 1:203–207

    Article  CAS  Google Scholar 

  • Ventafridda V, Spoldi E, Caraceni A, Tamburini M, De Conno F (1986b) The importance of continuous subcutaneous morphine administration for cancer pain control. Pain Clin 1:47–55

    Google Scholar 

  • Ventafridda V, Oliveri E, Caraceni A, Spoldi E, De Conno F, Saita L, Ripamonti C (1987) A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Management 2:77–81

    Article  Google Scholar 

  • Ventafridda V, Saita L, Barletta L, Sbanotto A, De Conno F (1989) Clinical observations in controlled-release morphine in cancer pain. J Pain Symptom Management 4:124–129

    Article  CAS  Google Scholar 

  • Vijayaram S, Bhargava K, Ramamani, Chandrasekhar, Sudharshan, Heranjal R, Lobo B (1989) Experience of oral morphine for cancer pain relief. J Pain Symptom Management 4:130–134

    Article  CAS  Google Scholar 

  • Waldman SD, Feldstein GS, Allen ML (1986) A trouble-shooting guide to the subcutaneous epidural implantable reservoir. J Pain Symptom Management 2:217–222

    Article  Google Scholar 

  • Waldman SD, Feldstein GS, Allen ML (1987) Neuroadenolysis of the pituitary: Description of a modified technique. J Pain Symptom Management 2:45–49

    Article  CAS  Google Scholar 

  • Walker VA, Hoskin PJ, Hanks GW, White ID (1988) Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Management 3:145–149

    Article  CAS  Google Scholar 

  • Walsh TD (1989) Cancer pain. In: Walsh TD (ed) Symptom control. Blackwell Scientific Publications, Inc., Boston, pp 329–343

    Google Scholar 

  • Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. (1982) Amitriptyline versus placebo in post-herpetic neuralgia. Neurology 32:671–673

    PubMed  CAS  Google Scholar 

  • Wedley JR (1989) Nerve blocks. In: Walsh TD (ed) Symptom control. Blackwell Scientific Publications, Inc., Boston, pp 365–377

    Google Scholar 

  • Wilkes E (1984) Dying now. Lancet i:950–952

    Google Scholar 

  • Yanagida H, Suwa K, Trouwborst A, Erdmann W, Corssen G (1988) Electrical stimulation of the pituitary: its use in the treatment of cancer pain. Pain Clin 2:225–228

    Google Scholar 

Download references

Authors
  1. C. Terrell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Wedley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial Cancer Research Fund Clinical Oncology Unit, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital, London, SE1 9RT, UK

    R. D. Rubens BSc, MD, FRCP (Professor) (Professor)

  2. Department of Nuclear Medicine, Guy’s Hospital, London, SE1 9RT, UK

    I. Fogelman BSc, MD, FRCP (Consultant Physician) (Consultant Physician)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag London Limited

About this chapter

Cite this chapter

Terrell, C., Wedley, J.R. (1991). Symptomatic and Supportive Care. In: Rubens, R.D., Fogelman, I. (eds) Bone Metastases. Springer, London. https://doi.org/10.1007/978-1-4471-3254-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3254-7_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3256-1

  • Online ISBN: 978-1-4471-3254-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation